Antitumor agent-61
Antitumor agent-61 (Compound 9b), Irinotecan (Ir) derivative, is a potential antitumor agent. Antitumor agent-61 displays potent activity with IC50s of 0.92, 1.39, 1.75, 2.20, 3.05 and 3.23 μM against five human cancer cells SK-OV-3, SK-OV-3/CDDP, U2OS, MCF-7, A549 and MG-63, respectively. Antitumor agent-61 induces SK-OV-3 cells apoptosis through mitochondrion pathways.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 2408917-12-2
- Formel: C54H63FN5O10P
- Molecular Weight:992.08
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
3.05 μM
Compound: 9b
|
Cytotoxicity against human A549 cells assessed as reduction in cell growth by MTT assay
Cytotoxicity against human A549 cells assessed as reduction in cell growth by MTT assay
|
[PMID: 31972391] |
| MCF7 | IC50 |
2.2 μM
Compound: 9b
|
Cytotoxicity against human MCF-7 cells assessed as reduction in cell growth by MTT assay
Cytotoxicity against human MCF-7 cells assessed as reduction in cell growth by MTT assay
|
[PMID: 31972391] |
| MG-63 | IC50 |
3.23 μM
Compound: 9b
|
Cytotoxicity against human MG-63 cells assessed as reduction in cell growth by MTT assay
Cytotoxicity against human MG-63 cells assessed as reduction in cell growth by MTT assay
|
[PMID: 31972391] |
| SK-OV-3 | IC50 |
0.92 μM
Compound: 9b
|
Cytotoxicity against human SK-OV-3 cells assessed as reduction in cell growth by MTT assay
Cytotoxicity against human SK-OV-3 cells assessed as reduction in cell growth by MTT assay
|
[PMID: 31972391] |
| U2OS | IC50 |
1.75 μM
Compound: 9b
|
Cytotoxicity against human U2OS cells assessed as reduction in cell growth by MTT assay
Cytotoxicity against human U2OS cells assessed as reduction in cell growth by MTT assay
|
[PMID: 31972391] |
In Vitro
Antitumor agent-61 (compound 6b) shows anti-proliferation activity with IC50 values of 3.05, 2.20, 3.23, 1.75, 0.92 and 1.39 μM for A549, MCF-7, MG-63, U2OS, SK-OV-3 and SK-OV-3/CDDP cells[1].
Antitumor agent-61 (compound 6b) (50-150 μM) shows a certain inhibitory activity against Topo I at 150 μM[1].
Antitumor agent-61 (compound 6b) (5-10 μM; 24 hours, SK-OV-3 cells) induces apoptosis through mitochondrial pathway. Decrease the MMP level and increase ROS level in a dose-dependent manner [1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:SK-OV-3 cells
-
Concentration:5.0 and 10 μM
-
Incubation Time:24 hours
-
Result:Increased the percentage of apoptosis cells (including the early and late apoptosis) from 21.11% (5 μM) to 32.27% (10 μM), respectively and the apoptosis rate was significantly greater than that of Ir.
-
Cell Line:SK-OV-3 cells
-
Concentration:5.0 and 10 μM
-
Incubation Time:24 hours
-
Result:Increased the percentage of S stage in a dose-dependent manner.
-
Cell Line:SK-OV-3 cells
-
Concentration:5.0 and 10 μM
-
Incubation Time:24 hours
-
Result:Decreased the expression of antiapoptotic protein Bcl-2, while increased pro-apoptotic Bax and caspase expression.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c nude mice with SK-OV-3 xenograft[1]
-
Dosage:10 and 20 mg/kg
-
Administration:Subcutaneous injection; Twice daily, for 28 days.
-
Result:Suppressed tumor growth by 47.7% and 56.8% for 10 and 20 mg/kg, respectively, without affecting body weight or causing any overt adverse effects.
Chemical Information
-
CAS. Nr. 2408917-12-2
-
Molecular Weight 992.08
-
Formel C54H63FN5O10P
-
SMILES
O=C(N1CCC(CC1)N2CCCCC2)OC3=CC4=C(CC)C5=C(C6=CC7=C(COC(C7(CC)OC(CCCC8=CC=C(NC(P(OCC)(OCC)=O)C9=CC=C(C=C9)F)C=C8)=O)=O)C(N6C5)=O)N=C4C=C3
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)